GoingToMeet

Drug delivery continues to be increasingly important sector in the pharmaceutical industry and has undergone rapid growth in the last few years.

Why Attend?

Key benefits:

• Examine the limitations of leading drug delivery technologies
• Discuss the changing patent landscape for drug delivery
• Understand the latest formulation and regulatory standards
• Gain advice on how do effectively develop and maintain drug delivery deal making in this financial climate
• Assess the future of innovations in the drug formulations technologies in the drug industry
• Network with key industry players from pharma, biotech, device and drug delivery indust

Key Speakers
• Dr. Sven Stegemann, Director, Pfizer
• Dr. Norbert Rasenack, Fellow Inhalation Development, Novartis
• Dr. Jan Möschwitzer, Head Early Pharmaceutical Development, Solvay
• Dr. Oliver Steinbach, Department Head, Philips Research Laboratories
• Dr. Joel Richard, Senior Director, Head of Drug Product Development, Ipsen
• Dr. Duncan F Rogers, Reader, National Heart & Lung Institute, Imperial College London
• Dr. Dejan Djuric, R&D Project Management Excipients, BASF
• Dr. Cheryl Barton, Managing Director, Pharmavision
• Gerry Kamstra, Partner, IP & Life Sciences, Bird and Bird
• Prof. Marc Brown, CSO, MedPharm
• Craig Thomson, Director European Patent Attorney, Murgitroyd & Company
• Dr. Giuseppe Battaglia, Senior Lecturer in Bionanotechnology, University of Sheffield
• Dr. Piet Christiaens, Scientific Director, Toxikon Europe
• Dr Pierandrea Esposito, Associate Director, SiTec PharmaBio